课题基金 / 基金详情

LOW FAT DIET AND BREAST CANCER RECURRENCE, OUTCOME TRIAL

LOW FAT DIET AND BREAST CANCER RECURRENCE, OUTCOME TRIAL
低脂饮食和乳腺癌复发，结果试验
批准号：
6306627
负责人：
ROWAN T. CHLEBOWSKI
金额：
$0.1万
依托单位：
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
1999
资助国家：
美国
项目状态：
已结题
起止时间：
1999-12-01 至 2000-11-30
来源：
https://reporter.nih.gov/project-details/6306627
关键词：
breast neoplasms clinical research clinical trials combination cancer therapy dietary control dietary lipid human subject human therapy evaluation longitudinal human study neoplasm /cancer nutrition therapy neoplasm /cancer relapse /recurrence neoplasm /cancer surgery nutrition related tag outcomes research postoperative state therapy compliance women's health

项目摘要

项目成果

ROWAN T. CHLEBOWSKI的其他基金

相似基金

相关文献

中文摘要
翻译
减少饮食脂肪摄入量是一种概念性的辅助乳腺癌治疗的新方法。支持评估饮食脂肪摄入量减少对局部乳腺癌患者管理的基本原理是：对低（日本）饮食摄入量国家与高（西方）饮食摄入量国家患者分期生存率的主要差异的流行病学观察；膳食脂肪摄入量与临床预后因素的关系体重增加的不利影响。
英文摘要
Dietary fat intake reduction is a conceptually new approach to adjuvant breast cancer management. The rationale supporting evaluation of dietary fat intake reduction in management of patients with localized breast cancer is based on: epidemiologic observations of major differences in stage-by-stage survival of patients comparing outcome in countries with low (JAPAN) vs high (Western) diet- ary intakes; relationships between dietary fat intake and factors prognostic of clinical outcomes; adverse effects of weight gain.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
THE SELENIUM AND VITAMIN E CHEMOPREVENTION TRIAL (SELECT)
A PHASE III RANDOMIZED STUDY OF EXEMESTANE PLUS PLACEBO VERSUS EXEMESTANE PLU
RESPIRATORY ANCILLARY STUDY (RAS) AS A SUBSTUDY OF SELECT TRIAL
WEIGHT LOSS IN PUBLIC HOSPITAL BREAST CANCER PATIENTS
海外基金